What you should know:
1. The CE mark was based on supporting clinical data.
2. AxioMed first received a CE mark in 2009. This mark will allow AxioMed to launch its Cervical Disc commercially in European, Asian, Latin American and Australian markets.
3. AxioMed has an investigational device exemption for its Lumbar Disc, and has more than five years of clinical follow-up data.
More articles on orthopedic:
Is price transparency positive or negative for spine? 3 surgeons weigh in
How Cleveland Clinic is growing in spine: 3 Qs with Dr. Michael Steinmetz
3 spine, neurosurgeons recently receiving honors
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
